期刊文献+

扶正固本汤防治支气管哮喘缓解期临床探讨 被引量:6

Clinical Study of Fuzheng Guben Decoction Prevention of Bronchial Asthma in Remission Stage
原文传递
导出
摘要 目的:探讨扶正固本汤对缓解期支气管哮喘患者临床疗效。方法:将200例支气管哮喘缓解期患者分为两组,扶正固本汤口服治疗组和对照组各100例。临床治疗2个月后随访2年,观察患者疗效、肺功能和血清免疫球蛋白IgG、IgE、T细胞亚群的变化。结果:治疗前后的自身对照,治疗组每年的哮喘复发次数较治疗前明显减少,肺功能明显改善,(P<0.05),患者T淋巴细胞亚群CD8明显增加,CD4/CD8细胞比值降低(P<0.05)。结论:扶正固本汤治疗缓解期支气管哮喘患者临床治疗效果明显。 Objective: To investigate the Fuzheng Guben decoction on remission in patients with bronchial asthma clinical efficacy fruit. Methods :200 cases of bronchial asthma in remission stage were divided into two groups, the strengths of soup Fuzheng oral treatment group and control group 100 cases each. Clinical treatment 2 months after 2 years follow - up to observe the patients, pulmonary function and serum immunoglobulin lgG, IgE, T cell subsets changes. Results : before and after treatment of self -control, the treatment group the number of annual asthma relapse than before treatment a significant decrease in lung function improved significantly, (P 〈 0.05), patients with T - lymphocyte subsets CDs significantly increased, CD4/CD8 cell ratio decreased (P 〈 O. 05). Conclusion:Fuzheng Guben decoction for remission in patients with bronchial asthma clinical treatment effect.
作者 刘增运
机构地区 嵊州市人民医院
出处 《中华中医药学刊》 CAS 2009年第11期2462-2464,共3页 Chinese Archives of Traditional Chinese Medicine
关键词 扶正固本汤 哮喘缓解期 T淋巴细胞亚群 肺功能 中医药疗法 Fuzheng Guben decoction asthma remission T - lymphocyte subsets lung function Chinese medicine treatment
  • 相关文献

参考文献5

二级参考文献25

共引文献41

同被引文献65

  • 1赵波,张睿.支气管哮喘病因探析[J].辽宁中医药大学学报,2009,11(1). 被引量:4
  • 2陈济明,李一禄,黄平,周燕宁,杜秀芳,聂莉.布地奈德对支气管哮喘患者Th17/Treg平衡的干预机制研究[J].中华哮喘杂志(电子版),2012,6(5):329-333. 被引量:10
  • 3龚臣,邓静敏.Th17/Treg在支气管哮喘发病机制中的作用及研究进展[J].中华哮喘杂志(电子版),2013,7(3):41-45. 被引量:54
  • 4翁俊良,郑义珊,马琼凤.小剂量布地奈德粉吸入剂治疗轻度支气管哮喘患者的远期疗效[J].中华结核和呼吸杂志,2005,28(2):88-92. 被引量:50
  • 5Shen HH,Ochkur SI,McGarry MP,et al.A Causative relationshipexists between eosinophils and the development of allergy pulmonarypathologies in the mouse[J]. J Immunol,2003,170:3296-3305.
  • 6Kitayama J,Mackay CR,Ponath PD,et al.The C-C chemokinereceptor CCR3 participates in stimulation of eosinophil arrest oninflammatory endothelium in shear flow[J]. Journal of ClinicalInvestigation,1998,101(9):2017-2024.
  • 7Giembycz MA,Lindsay MA.Pharmacology of the Eosinophil[J]. Pharmacological Reviews,1999,51:219-220.
  • 8Sehmi R,Baatjes AJ,Denburg JA.Hemopoietic progenitor cellsand hemopoietic factors:potential targets for treatment of allergicinflammatory diseases[J]. Curr Drug Targets Inflamm Allergy,2003,2:271-278.
  • 9Blau HM,Brazleton TR,Weimann JM.The evolving concept of astem cell:entity or function[J]. Cell,2001,105:829-841.
  • 10Dorman SC,Babirad I,Post J,et al.Progenitor egress from thebone marrow after allergen challenge:role of stromal cell-de-rived factor lalpha and eotaxin[J]. J Allergy Clin Immunol,2005,115:501-507.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部